SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-270455"
 

Search: onr:"swepub:oai:DiVA.org:uu-270455" > Changes in CSF chol...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

Karami, Azadeh (author)
Karolinska Institutet
Eyjolfsdottir, Helga (author)
Karolinska Institutet
Vijayaraghavan, Swetha (author)
Karolinska Institutet
show more...
Lind, Goran (author)
Karolinska Institutet
Almqvist, Per (author)
Karolinska Institutet
Kadir, Ahmadul (author)
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.
Linderoth, Bengt (author)
Karolinska Institutet
Andreasen, Niels (author)
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Geriatr, Stockholm, Sweden.
Blennow, Kaj, 1958 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Wall, Anders (author)
Uppsala universitet,Radiologi
Westman, Eric (author)
Karolinska Institutet
Ferreira, Daniel (author)
Karolinska Institutet
Wiberg, Maria Kristoffersen (author)
Karolinska Institutet
Wahlund, Lars-Olof (author)
Karolinska Institutet
Seiger, Ake (author)
Karolinska Institutet
Nordberg, Agenta (author)
Karolinska Institutet
Wahlberg, Lars (author)
NsGene Inc, Providence, RI USA.
Darreh-Taher, Taher (author)
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Geriatr, Stockholm, Sweden.
Eriksdotter, Maria (author)
Karolinska Institutet
show less...
Karolinska Institutet Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden (creator_code:org_t)
2015-02-09
2015
English.
In: Alzheimer's & Dementia. - : Wiley. - 1552-5260 .- 1552-5279. ; 11:11, s. 1316-1328
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Introduction: The extensive loss of central cholinergic functions in Alzheimer's disease (AD) brain is linked to impaired nerve growth factor (NGF) signaling. The cardinal cholinergic biomarker is the acetylcholine synthesizing enzyme, choline acetyltransferase (ChAT), which has recently been found in cerebrospinal fluid (CSF). The purpose of this study was to see if EC-NGF therapy will alter CSF levels of cholinergic biomarkers, ChAT, and acetylcholinesterase. Method: Encapsulated cell implants releasing NGF (EC-NGF) were surgically implanted bilaterally in the basal forebrain of six AD patients for 12 months and cholinergic markers in CSF were analyzed. Results: Activities of both enzymes were altered after 12 months. In particular, the activity of soluble ChAT showed high correlation with cognition, CSF tau and amyloid-beta, in vivo cerebral glucose utilization and nicotinic binding sites, and morphometric and volumetric magnetic resonance imaging measures. Discussion: A clear pattern of association is demonstrated showing a proof-of-principle effect on CSF cholinergic markers, suggestive of a beneficial EC-NGF implant therapy.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

Alzheimer's disease
Nerve growth factor
Choline acetyltransferase
Acetyl cholinesterase
tau
Amyloid-beta
Nicotine receptors
PET
MRI

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view